Construction and validation of the chronic acquired polyneuropathy patient-reported index (CAP-PRI): A disease-specific, health-related quality-of-life instrument

Muscle Nerve. 2016 Jun;54(1):9-17. doi: 10.1002/mus.24985. Epub 2015 Dec 29.

Abstract

Introduction: Generic health-related quality-of-life (HRQOL) patient-reported outcome measures have been used in patients with chronic immune-mediated polyneuropathies. We have created a disease-specific HRQOL instrument.

Methods: The chronic acquired polyneuropathy patient-reported index (CAP-PRI) was developed and validated in multiple steps. Items were initially generated through patient and specialist input. The performance of the preliminary 20 items was analyzed via a prospective, 5-center study involving chronic immune-mediated polyneuropathy patients.

Results: Data analysis suggested modification to a 15-item scale with 3 response categories rather than 5. The final CAP-PRI was validated in another prospective, 5-center study. The CAP-PRI appeared to be a unidimensional outcome measure that fit the Rasch model in our multicenter cohort. It correlated appropriately with outcome measures commonly used in this patient population.

Conclusions: The CAP-PRI is a simple disease-specific HRQOL measure that appears to be useful for clinical care and possibly also for clinical trials. Muscle Nerve 54: 9-17, 2016.

Keywords: CAP-PRI; chronic inflammatory demyelinating polyneuropathy; immune-mediated polyneuropathy; patient-reported outcome; quality of life.

Publication types

  • Multicenter Study

MeSH terms

  • Female
  • Humans
  • Male
  • Polyneuropathies / diagnosis*
  • Polyneuropathies / psychology*
  • Prospective Studies
  • Psychometrics*
  • Quality of Life / psychology*
  • Reproducibility of Results
  • Retrospective Studies
  • Statistics, Nonparametric
  • Surveys and Questionnaires